Skip to main content
. 2023 Jan 5;42:4. doi: 10.1186/s13046-022-02568-y

Fig. 3.

Fig. 3

Total irAE cases and serious irAE cases for seven FDA-approved ICIs among various cancer types. A Total number of irAE cases for seven FDA-approved ICIs: patients with lung cancer ranked first or second for the highest number of total irAEs. B Number of serious irAEs for seven FDA-approved ICIs: patients with lung cancer also ranked first or second for serious irAEs